Spectranetics to Host First Quarter 2016 Conference Call on April 28, 2016
April 07, 2016 16:00 ET
|
The Spectranetics Corporation
COLORADO SPRINGS, Colo., April 07, 2016 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) today announced that the Company will release first quarter 2016 financial results after the...
Spectranetics Names Udo Scheiner as Senior Vice President, International Operations
March 24, 2016 16:00 ET
|
The Spectranetics Corporation
COLORADO SPRINGS, Colo., March 24, 2016 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (NASDAQ:SPNC) today announced that Udo Scheiner has been named Senior Vice President, International...
Spectranetics Achieves Fourth Quarter 2015 Revenue of $65.2 Million
February 25, 2016 16:05 ET
|
The Spectranetics Corporation
COLORADO SPRINGS, Colo., Feb. 25, 2016 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (NASDAQ:SPNC) today reported financial results for the three months and year ended December 31,...
Spectranetics to Hold 2015 Fourth Quarter Financial Results Conference Call on February 25, 2016
February 09, 2016 16:07 ET
|
The Spectranetics Corporation
COLORADO SPRINGS, Colo., Feb. 09, 2016 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) today announced that the Company will release 2015 fourth quarter financial results after...
Spectranetics Receives FDA 510(k) Clearance for Bridge™ Occlusion Balloon for Lead Extraction Procedures
February 08, 2016 07:30 ET
|
The Spectranetics Corporation
COLORADO SPRINGS, Colo., Feb. 08, 2016 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (NASDAQ:SPNC) today announced U.S. Food and Drug Administration (FDA) Premarket Notification 510(k)...
Spectranetics to Present at the J.P. Morgan 34th Annual Healthcare Conference
December 28, 2015 13:05 ET
|
The Spectranetics Corporation
COLORADO SPRINGS, Colo., Dec. 28, 2015 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) today announced that its management will be presenting at the J.P. Morgan 34th Annual...
Spectranetics Announces FDA Submission of Bridge(TM) Occlusion Balloon for Lead Extraction Procedures
December 08, 2015 18:49 ET
|
The Spectranetics Corporation
COLORADO SPRINGS, Colo., Dec. 8, 2015 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (NASDAQ:SPNC) today announced U.S. Food and Drug Administration (FDA) Premarket Notification 510(k) submission...
Spectranetics Announces Debt Financing
December 07, 2015 16:01 ET
|
The Spectranetics Corporation
COLORADO SPRINGS, Colo., Dec. 7, 2015 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (NASDAQ:SPNC) announced today that it has completed the refinancing of its outstanding debt and closed on a new...
Spectranetics to Present at the 27th Annual Piper Jaffray Healthcare Conference
November 17, 2015 16:01 ET
|
The Spectranetics Corporation
COLORADO SPRINGS, Colo., Nov. 17, 2015 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) today announced that its management will be presenting at the 27th Annual Piper Jaffray...
Spectranetics Announces FDA Clearance of Turbo-Power(TM) Laser Atherectomy Catheter, Only Indicated Atherectomy Device for Treatment of In-Stent Restenosis
November 12, 2015 18:47 ET
|
The Spectranetics Corporation
COLORADO SPRINGS, Colo., Nov. 12, 2015 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (NASDAQ:SPNC) today announced receipt of U.S. Food and Drug Administration (FDA) 510(k) clearance of its...